Garden State Investment Advisory Services LLC Outlook Therapeutics, Inc. Transaction History

Garden State Investment Advisory Services LLC

  • $273 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.02 - $1.89 $915 - $1,697
898 Added 6.41%
14,898 $25.9 Million
Q4 2022

Feb 13, 2023
BUY
$0.87 - $1.33 $12,180 - $18,620
14,000 New
14,000 $15.1 Million

Others Institutions Holding OTLK

# of Institutions
7
Shares Held
67.1K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.66B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Garden State Investment Advisory Services LLC Portfolio

Follow Garden State Investment Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garden State Investment Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garden State Investment Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email